Interestingly, treating mice that developed AML with IL-2 linked to diphtheria toxin (IL-2DT), followed by anti-PDL1 monoclonal antibody treatment, markedly reduced the AML tumor burden[25]. Here, CD274 is linked to acute myeloid leukemia.